Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc.

Overview
Date Founded

1960

Headquarters

81 Wyman Street Waltham, Massachusetts, 02454, United States

Type of Company

Public

Employees (Worldwide)

75K

Industries

Industrial Machinery & Manufacturing
Wholesale: Industrial Products & Manufacturing
Medical Products & Equipment
Hospitals & Patient Services
Computer Software
Biotechnology

Company Description

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Contact Data
Trying to get in touch with decision makers at Thermo Fisher Scientific, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Chairman, President & Chief Executive Officer

Senior Vice President & Chief Financial Officer

Executive Vice President & Chief Operating Officer

Senior Vice President & General Counsel

Senior Vice President & Chief Information Officer

Chief Scientific Officer

Chief Accounting Officer

Chief Human Resources Officer & Senior Vice President

Vice President & Chief Communications Officer

Board of Directors

Chairman, President & Chief Executive Officer at Thermo Fisher Scientific, Inc.

Co-Chief Executive Officer at Thomas H. Lee Partners LP

Former Executive Vice President & Chief Financial Officer at Merck & Co., Inc.

Director at Essity AB

Chairman & Chief Executive Officer at Deutsch Engineered Connecting Devices Corp.

Chief Financial Officer at Uber Technologies, Inc.

Chief Business Officer at University of Texas at Austin - Dell Medical School

Founder at Dragonfly Therapeutics, Inc.

MBA Class of Professor of Business Administration & Senior Associate Dean for Harvard Business School Online at Harvard University - Harvard Business School

Chairman at Stonegate Capital LLC

Paths to Thermo Fisher Scientific, Inc.
Potential Connections via
Relationship Science
You
Thermo Fisher Scientific, Inc.
Owners & Shareholders
Details Hidden

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm utilizes fundamental research to gather in-depth information on markets and companies around the world. They also employ a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Details Hidden

Price Associates uses a complex and multifaceted approach to investment analysis and asset management decisions. They integrate ESG factors into their investment research process. The firm focuses on the ESG factors they consider most likely to have a material impact on the performance of securities in client accounts. Price Associates also focuses on their analytical process on three areas of research: the industry, the contracts issued, and the creditworthiness of each individual issuer.

Details Hidden

MFS Investment Management employs a variety of methods to evaluate securities, including fundamental analysis and quantitative analysis. The firm offers fundamental, active and research-driven equity strategies that strive for less volatility relative to benchmarks and greater value through changing markets. Fixed income strategy offers total return focused and credit-oriented approach. Multi-Asset strategy is goal-oriented, diversified and disciplined investment approach that combines broad diversification across multiple asset classes, active asset allocation, and bottom-up security selection. MFS' retirement solutions are designed with a goal of maximizing growth and supporting income over a lifetime by focusing on long-term returns. MFS Blended Research is an approach to active equity management that combines the firm’s fundamental research expertise with highly systematic quantitative research.

Recent Transactions
Details Hidden

Thermo Fisher Scientific, Inc. purchases Qiagen N.V.

Details Hidden

Thermo Fisher Scientific, Inc. purchases GlaxoSmithKline Plc /Cork Site from GlaxoSmithKline Plc

Details Hidden

Thermo Fisher Scientific, Inc. purchases Brammer Bio LLC from Ampersand Management LLC

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Investment Advisor

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onKohlberg Kravis Roberts & Co. LP, PHC Holdings Corp. purchase from Thermo Fisher Scientific, Inc. resulting in a new company Epredia

Advisors & Consultants
Legal Advisor

Partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP

Legal Advisor

Partner at Covington & Burling LLP

Advisor

President at Shaker Recruitment Advertising & Communications, Inc.

Clients

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22, and GGF2 (Cimaglermin alfa). The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.

bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The firm develops testing. detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.

Coupa Software, Inc. engages in the provision of business spend management (BSM) solutions. Its products include invoice, expense, pay, spend analysis, strategic sourcing, contract management contingent workforce, and supplier management. The company was founded by Noah Eisner and Dave Stephens in 2006 and is headquartered in San Mateo, CA.

Key Stats and Financials As of 2019
Market Capitalization
$185B
Total Enterprise Value
$147B
Earnings Per Share
$9.17
Revenue
$25.5B
Net Profit
$3.7B
Total Equity
$29.7B
EBITDA
$6.54B
EBITDAMargin
25.59%
Total Debt
$18.5B
Enterprise Value / Sales
5.75x
Enterprise Value EBITDAOperating
22.38x
TEVNet Income
39.77x
Debt TEV
0.13x
Three Year Compounded Annual Growth Rate Of Revenue
11.81%
Non-Profit Donations & Grants Received
Investments
Details Hidden

Synthetic Genomics, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Details Hidden

Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA.

Details Hidden

EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California.

Investors
Details Hidden

Co-Founder at Future

Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Life Peer at United Kingdom House of Lords

Suppliers
Luminex Corp. Medical Support Services | Austin, TX

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Deutsche Post AG Internet Software & Services | Bonn, Deu

The Deutsche Post and DHL corporate brands offer a one-of-a-kind portfolio of logistics and communications services. The Group provides its customers with both easy to use standardized products as well as innovative and tailored solutions ranging from dialog marketing to industrial supply chains. About 475,000 employees in more than 220 countries and territories form a global network focused on service, quality and sustainability. With programs in the areas of climate protection, disaster relief and education, the Group is committed to social responsibility.

Response Biomedical Corp. Other Business & Consulting Services | Vancouver, Canada

Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies. The firm serves the medical central-lab testing, point of care testing, and on-site environmental testing markets. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company was founded by William Joseph Radvak on August 20, 1980 and is headquartered in Vancouver, Canada.

Awards & Honors
Rank #164
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #164
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thermo Fisher Scientific, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thermo Fisher Scientific, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Thermo Fisher Scientific, Inc..